54.14 (-%)
As of Nov 20, 2024
Source:
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular disorders with high unmet medical need.
| Country | United States |
| Headquarters | lexington, massachusetts |
| Phone Number | 617-314-6297 |
| Industry | manufacturing |
| CEO | Jasbir Seehra, Ph.D. |
| Website | www.clinicaltrials.gov |